SUN-180 - Gensci155, A Novel Long-Acting IGF-1 Analog Ameliorates Hyperoxia-Induced Bronchopulmonary Dysplasia in A Neonatal Rat Model

Abstract Poster Presenter(s)

• JM

  Jing Ma, GS11592

  Changchun Genescience Pharmaceuticals Co., Ltd., Shanghai, China
  Shanghai, China (People's Republic)

Co-Author(s)

• NL

  NA LIU, scientist

  Changchun Genescience Pharmaceuticals Co., Ltd., Shanghai, China
  Shanghai, China (People's Republic)
• XG

  Xiaoyu Gu, NA

  Changchun Genescience Pharmaceuticals Co., Ltd., Shanghai, China
  Shanghai, China (People's Republic)
• PQ

  Peng Qi, scientist

  Changchun Genescience Pharmaceuticals Co., Ltd., Shanghai, China
  Shanghai, China (People's Republic)
• FD

  Fangfang Du, NA

  Changchun Genescience Pharmaceuticals Co., Ltd., Shanghai, China
  Shanghai, China (People's Republic)

Senior Author/Primary Investigator(s)

• XW

  XIAOZHEN WANG, n/a

  VP
  Changchun Genescience Pharmaceuticals Co., Ltd., Shanghai, China
  Shanghai, China (People's Republic)

Co-Author(s)

• HZ

  Haizhou Zhang, Ph.D.

  GeneScience Pharmaceuticals
  shanghai, China (People's Republic)
• FR

  Feifei Ren, NA

  Changchun Genescience Pharmaceuticals Co., Ltd., Shanghai, China
  Shanghai, China (People's Republic)
• HZ

  Hongyang Zhuang, NA

  Changchun Genescience Pharmaceuticals Co., Ltd., Shanghai, China
  Shanghai, China (People's Republic)
• MC

  Mingjie Chen, NA

  Changchun Genescience Pharmaceuticals Co., Ltd., Shanghai, China
  Shanghai, China (People's Republic)
• LK

  LiShan Kang, scientist

  Changchun Genescience Pharmaceuticals Co., Ltd., Shanghai, China
  Shanghai, China (People's Republic)